Loading...
Amneal Pharmaceuticals Community
NasdaqGS:AMRX Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 16 Fair Values set on narratives written by author
Community Investing Ideas
AMRX: Recent FDA Approvals And Pipeline Launches Will Drive Upside Momentum
Key Takeaways Diversification into branded, complex products and biosimilars, along with global expansion and partnerships, positions the company for continued revenue and profit growth. Investments in manufacturing, supply chain optimization, and improved financial flexibility strengthen operational resilience and support margin improvement amid shifting healthcare dynamics.Read more
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AN
US$13.5
13.4% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
7.97% p.a.
Profit Margin
5.58%
Future PE
26.1x
Share price in 2028
US$16.42